Is Beaten-Down Phibro Animal Health Stock a Buy Following an Insider Purchase of 10,000 Shares?
Written by Cory Renauer for The Motley Fool -> Corcoran purchased 10,000 shares for a transaction value of approximately ~$318,000 on May 29, 2026. The buy increased his direct ownership by 31.79%, bringing his post-transaction direct holdings to 41,459 shares. All shares were
Corcoran purchased 10,000 shares for a transaction value of approximately ~$318,000 on May 29, 2026.
The buy increased his direct ownership by 31.79%, bringing his post-transaction direct holdings to 41,459 shares.
All shares were acquired through direct open-market purchases; no indirect holdings or derivative activity was reported.
Corcoran retains 41,459 shares of Common Stock directly following the transaction.
E. Thomas Corcoran, Director of Phibro Animal Health Corporation (NASDAQ:PAHC) , reported the acquisition of 10,000 shares of Common Stock at a weighted average price of $31.77 per share on May 29, 2026, according to a SEC Form 4 filing .
Transaction value based on SEC Form 4 weighted average purchase price ($31.77); post-transaction value based on May 29, 2026 transaction price ($31.77).
* 1-year price change calculated using June 12, 2026, as the reference date.
Phibro Animal Health Corporation is a leading provider of animal health and mineral nutrition products, serving a global customer base with a focus on food animal production. The company leverages a diversified product portfolio and established distribution channels to maintain a competitive position in the animal health industry.
